International Patent: MULTISPECIFIC IMMUNE CELL ENGAGER ANTIBODIES OR ANTIGEN BINDING FRAGMENTS THEREOF

GENEVA, Aug. 21 -- NEXTPOINT THERAPEUTICS, INC. filed a patent application (US2026/015287) for “MULTISPECIFIC IMMUNE CELL ENGAGER ANTIBODIES OR ANTIGEN BINDING FRAGMENTS THEREOF”. With publication no. WO/2026/174211, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....